Latest News
Would you perform carotid artery stenting with embolic protection in an 80 year old man with an asymptomatic, 80-99%, unilateral internal carotid artery stenosis?
Always, if the anatomy can be negotiated.
Only in a clinical registry or trial.
Only if transcranial Doppler (TCD) detects cerebral emboli, denoting high risk for adverse neurological events.
Never.
Refer for carotid endarterectomy if not surgically high-risk.
[View results]
SIS 2009 Symposia

Course Description
The SIS 2009 Coronary Artery Disease Symposium will focus on the latest advances in the diagnosis and treatment of complex coronary artery disease.  Utilizing the Seattle Science Foundation’s state-of-the-art facilities, this symposium will feature didactic lectures; discussions regarding evidence-based practice of cardiology patients; updates and demonstrations on the advances in interventional and surgical technologies and techniques; hands-on anatomical, imaging, and technological review using cadaveric hearts; case-based presentations; and live case demonstrations broadcast from various catheterization laboratories.

Needs Statement
The field of interventional cardiology is dynamic and constantly evolving as new devices, technologies and techniques are developed to care for complex patients with coronary artery disease.  An annual update on this topic is necessary given new clinical trial results and device approvals that require those who do these procedures to keep current in order to provide the highest level of patient care.

Target Audience
This symposium is designed for physicians who specialize in interventional cardiology or conduct minimally invasive cardiac interventional procedures as a part of their practice.

Course Objectives
At the conclusion of this conference, the participants will provide better patient care through an increased ability to:

  • Compare and contrast the current and evolving drug-eluting stent platforms
  • Describe approaches to complex PCI including left main disease and chronic total occlusions
  • Discuss the status of current clinical trials in coronary artery disease
  • Explain techniques for bifurcation therapy
  • Evaluate case studies submitted by faculty and attendees
  • Identify optimal pharmacology for percutaneous coronary intervention
  • Interpret invasive imaging modalities
  • Utilize strategies for design modification devices
  • Discuss emerging technologies
  • Utilize Clinical Outcomes Assessment Program (COAP) data from Washington State to strategize how to improve patient outcomes
  • Explain how real-world registries can influence clinical behavior
  • Demonstrate improved knowledge of treatment options for coronary artery disease
  • Utilize evidence-based research data to aid in the selection of the most appropriate stent for individual patients

Accreditation with Commendation
Swedish Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Category 1 Credits
Swedish Medical Center designates this educational activity for a maximum of 10 AMA PRA Category 1 Credits™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Confidentiality Agreement
Because live-case demonstrations will be presented, you are reminded that any patient information you may receive as part of this Continuing Medical Education program is considered confidential.  Confidential patient information includes all information that could be used to identify the individual patient.  By participating in this CME program, you agree to maintain the confidentiality of all patient information and not release that information to any third party.

Disclosure Statement
It is the policy of Swedish Medical Center and the SIS Course Planning Committee to ensure balance, independence, objectivity and scientific rigor in all of its sponsored educational programs. None of the content within the SIS Symposium may be influenced by industry involvement or support in any way. Any relationships between industry vendors and SIS faculty, either perceived or real, will be openly disclosed and disseminated at the SIS meeting.  Persons who have not completed a conflict of interest disclosure form will not be allowed to participate as faculty at SIS.

Planning Committee
Peter Casterella, MD
Amish Desai, MD
Mary Gregg, MD, MHA
Howard Lewis, MD
William Lombardi, MD
Kurt Owens
John L. Petersen II, MD
Mark Reisman, MD
R. Jeffrey Westcott, MD

SIS 2009 PROGRAM MANAGER
Laurie Turay, BA Ed